Javad Habibi

Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes

Javad Habibi, Annayya R. Aroor, James R. Sowers et al. · Cardiovascular Diabetology · 2017 · 265 citations · Full text

Cardiac defects contribute to the pathology of spinal muscular atrophy models

Monir Shababi, Javad Habibi, H. T. Yang et al. · Human Molecular Genetics · 2010 · 191 citations · Full text

Cardiac Muscle, Heart Failure, Genetics +25

Endothelial Mineralocorticoid Receptor Mediates Diet-Induced Aortic Stiffness in Females

Guanghong Jia, Javad Habibi, Annayya R. Aroor et al. · Circulation Research · 2016 · 173 citations · Full text

Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury

Annayya R. Aroor, Nitin A. Das, Andrea J. Carpenter et al. · Cardiovascular Diabetology · 2018 · 166 citations · Full text

Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet–Induced Arterial Stiffening in Female Mice

Vincent G. DeMarco, Javad Habibi, Guanghong Jia et al. · Hypertension · 2015 · 149 citations · Full text

Female Mice, Obesity, Metabolic Syndrome +16